Global Retirement Partners, LLC Clovis Oncology, Inc. Transaction History

Global Retirement Partners, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 15, 2021	SELL	$5.02 - $7.05 $6,525 - $9,165	-1,300 Closed	0 $0
Q1 2021 Apr 14, 2021	SELL	$4.81 - $10.34 $11,784 - $25,333	-2,450 Reduced 65.33%	1,300 $9,000
Q4 2020 Jan 13, 2021	SELL	$4.13 - $6.41 $21,166 - $32,851	-5,125 Reduced 57.75%	3,750 $18,000
Q3 2020 Oct 09, 2020	BUY	$4.82 - $7.72 $24,100 - $38,600	5,000 Added 129.03%	8,875 $52,000
Q4 2019 Jan 23, 2020	SELL	$3.0 - $16.43 $3,225 - $17,662	-1,075 Reduced 21.72%	3,875 $40,000
Q3 2019 Nov 19, 2019	BUY	$3.93 - $15.35 $12,183 - $47,585	3,100 Added 167.57%	4,950 $19,000
Q2 2019 Nov 19, 2019	BUY	$12.81 - $25.67 $16,012 - $32,087	1,250 Added 208.33%	1,850 $28,000
Q4 2018 Feb 22, 2019	BUY	$11.63 - $32.67 $6,978 - $19,602	600 New	600 $11,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Global Retirement Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Global Retirement Partners, LLC with notifications on news.